Covidien (Angioplasty Balloon Product Line) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Covidien (Angioplasty Balloon Product Line) General Information

Description

Developer of cardiac-treatment technology. The business is the creator of a product line of drug-coated angioplasty balloons.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Dublin
  • Ireland
Primary Industry
Surgical Devices
Corporate Office
  • Dublin
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covidien (Angioplasty Balloon Product Line) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covidien (Angioplasty Balloon Product Line)‘s full profile, request access.

Request a free trial

Covidien (Angioplasty Balloon Product Line) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Covidien (Angioplasty Balloon Product Line)‘s full profile, request access.

Request a free trial

Covidien (Angioplasty Balloon Product Line) FAQs

  • Where is Covidien (Angioplasty Balloon Product Line) headquartered?

    Covidien (Angioplasty Balloon Product Line) is headquartered in Dublin, Ireland.

  • What industry is Covidien (Angioplasty Balloon Product Line) in?

    Covidien (Angioplasty Balloon Product Line)’s primary industry is Surgical Devices.

  • Is Covidien (Angioplasty Balloon Product Line) a private or public company?

    Covidien (Angioplasty Balloon Product Line) is a Private company.

  • What is the current valuation of Covidien (Angioplasty Balloon Product Line)?

    The current valuation of Covidien (Angioplasty Balloon Product Line) is .

  • What is Covidien (Angioplasty Balloon Product Line)’s current revenue?

    The current revenue for Covidien (Angioplasty Balloon Product Line) is .

  • Who are Covidien (Angioplasty Balloon Product Line)’s investors?

    Covidien has invested in Covidien (Angioplasty Balloon Product Line).

  • When was Covidien (Angioplasty Balloon Product Line) acquired?

    Covidien (Angioplasty Balloon Product Line) was acquired on 27-Jan-2015.

  • Who acquired Covidien (Angioplasty Balloon Product Line)?

    Covidien (Angioplasty Balloon Product Line) was acquired by The Spectranetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process